img

Global Syndromic Multiplex Diagnostic Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Syndromic Multiplex Diagnostic Market Research Report 2024

Most patients with infectious illness have certain symptoms and signs that are indicative of a disease but becomes difficult to identify the actual causing agent. These set of signs and symptoms are referred to as syndrome.
According to MRAResearch’s new survey, global Syndromic Multiplex Diagnostic market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Syndromic Multiplex Diagnostic market research.
Key companies engaged in the Syndromic Multiplex Diagnostic industry include Abbott, Hologic, Bosch, Danaher, Johnson & Johnson, Danaher, Bio-Rad Laboratories, Luminex and bioMérieux, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Syndromic Multiplex Diagnostic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Syndromic Multiplex Diagnostic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Syndromic Multiplex Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Hologic
Bosch
Danaher
Johnson & Johnson
Danaher
Bio-Rad Laboratories
Luminex
bioMérieux
Qiagen
Alveo Technologies
Mesa Biotech
Applied BioCode
Akonni Biosystems
Diagenode Diagnostics
Segment by Type
Gastrointestinal Syndromic Multiplex Diagnostic
Central Nervous System Syndromic Multiplex Diagnostic
Others

Segment by Application


Hospitals
Diagnostics Laboratories
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Syndromic Multiplex Diagnostic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gastrointestinal Syndromic Multiplex Diagnostic
1.2.3 Central Nervous System Syndromic Multiplex Diagnostic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Syndromic Multiplex Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Syndromic Multiplex Diagnostic Market Perspective (2018-2033)
2.2 Syndromic Multiplex Diagnostic Growth Trends by Region
2.2.1 Global Syndromic Multiplex Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Syndromic Multiplex Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Syndromic Multiplex Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Syndromic Multiplex Diagnostic Market Dynamics
2.3.1 Syndromic Multiplex Diagnostic Industry Trends
2.3.2 Syndromic Multiplex Diagnostic Market Drivers
2.3.3 Syndromic Multiplex Diagnostic Market Challenges
2.3.4 Syndromic Multiplex Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue
3.1.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Syndromic Multiplex Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Syndromic Multiplex Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Syndromic Multiplex Diagnostic Revenue
3.4 Global Syndromic Multiplex Diagnostic Market Concentration Ratio
3.4.1 Global Syndromic Multiplex Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Syndromic Multiplex Diagnostic Revenue in 2022
3.5 Syndromic Multiplex Diagnostic Key Players Head office and Area Served
3.6 Key Players Syndromic Multiplex Diagnostic Product Solution and Service
3.7 Date of Enter into Syndromic Multiplex Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Syndromic Multiplex Diagnostic Breakdown Data by Type
4.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2024-2033)
5 Syndromic Multiplex Diagnostic Breakdown Data by Application
5.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Syndromic Multiplex Diagnostic Market Size (2018-2033)
6.2 North America Syndromic Multiplex Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Syndromic Multiplex Diagnostic Market Size by Country (2018-2023)
6.4 North America Syndromic Multiplex Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Syndromic Multiplex Diagnostic Market Size (2018-2033)
7.2 Europe Syndromic Multiplex Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Syndromic Multiplex Diagnostic Market Size by Country (2018-2023)
7.4 Europe Syndromic Multiplex Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Syndromic Multiplex Diagnostic Market Size (2018-2033)
9.2 Latin America Syndromic Multiplex Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Syndromic Multiplex Diagnostic Introduction
11.1.4 Abbott Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Hologic
11.2.1 Hologic Company Detail
11.2.2 Hologic Business Overview
11.2.3 Hologic Syndromic Multiplex Diagnostic Introduction
11.2.4 Hologic Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.2.5 Hologic Recent Development
11.3 Bosch
11.3.1 Bosch Company Detail
11.3.2 Bosch Business Overview
11.3.3 Bosch Syndromic Multiplex Diagnostic Introduction
11.3.4 Bosch Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.3.5 Bosch Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.4.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Syndromic Multiplex Diagnostic Introduction
11.5.4 Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.6.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.6.5 Danaher Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Introduction
11.7.4 Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Syndromic Multiplex Diagnostic Introduction
11.8.4 Luminex Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.8.5 Luminex Recent Development
11.9 bioMérieux
11.9.1 bioMérieux Company Detail
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Syndromic Multiplex Diagnostic Introduction
11.9.4 bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.9.5 bioMérieux Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Syndromic Multiplex Diagnostic Introduction
11.10.4 Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Alveo Technologies
11.11.1 Alveo Technologies Company Detail
11.11.2 Alveo Technologies Business Overview
11.11.3 Alveo Technologies Syndromic Multiplex Diagnostic Introduction
11.11.4 Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.11.5 Alveo Technologies Recent Development
11.12 Mesa Biotech
11.12.1 Mesa Biotech Company Detail
11.12.2 Mesa Biotech Business Overview
11.12.3 Mesa Biotech Syndromic Multiplex Diagnostic Introduction
11.12.4 Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.12.5 Mesa Biotech Recent Development
11.13 Applied BioCode
11.13.1 Applied BioCode Company Detail
11.13.2 Applied BioCode Business Overview
11.13.3 Applied BioCode Syndromic Multiplex Diagnostic Introduction
11.13.4 Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.13.5 Applied BioCode Recent Development
11.14 Akonni Biosystems
11.14.1 Akonni Biosystems Company Detail
11.14.2 Akonni Biosystems Business Overview
11.14.3 Akonni Biosystems Syndromic Multiplex Diagnostic Introduction
11.14.4 Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.14.5 Akonni Biosystems Recent Development
11.15 Diagenode Diagnostics
11.15.1 Diagenode Diagnostics Company Detail
11.15.2 Diagenode Diagnostics Business Overview
11.15.3 Diagenode Diagnostics Syndromic Multiplex Diagnostic Introduction
11.15.4 Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2018-2023)
11.15.5 Diagenode Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gastrointestinal Syndromic Multiplex Diagnostic
Table 3. Key Players of Central Nervous System Syndromic Multiplex Diagnostic
Table 4. Key Players of Others
Table 5. Global Syndromic Multiplex Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Syndromic Multiplex Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Syndromic Multiplex Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Syndromic Multiplex Diagnostic Market Share by Region (2018-2023)
Table 9. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Syndromic Multiplex Diagnostic Market Share by Region (2024-2033)
Table 11. Syndromic Multiplex Diagnostic Market Trends
Table 12. Syndromic Multiplex Diagnostic Market Drivers
Table 13. Syndromic Multiplex Diagnostic Market Challenges
Table 14. Syndromic Multiplex Diagnostic Market Restraints
Table 15. Global Syndromic Multiplex Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Syndromic Multiplex Diagnostic Market Share by Players (2018-2023)
Table 17. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syndromic Multiplex Diagnostic as of 2022)
Table 18. Ranking of Global Top Syndromic Multiplex Diagnostic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Syndromic Multiplex Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Syndromic Multiplex Diagnostic Product Solution and Service
Table 22. Date of Enter into Syndromic Multiplex Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Syndromic Multiplex Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2018-2023)
Table 26. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2024-2033)
Table 28. Global Syndromic Multiplex Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Syndromic Multiplex Diagnostic Revenue Market Share by Application (2018-2023)
Table 30. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Syndromic Multiplex Diagnostic Revenue Market Share by Application (2024-2033)
Table 32. North America Syndromic Multiplex Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Syndromic Multiplex Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Syndromic Multiplex Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Syndromic Multiplex Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Syndromic Multiplex Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Syndromic Multiplex Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Syndromic Multiplex Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Syndromic Multiplex Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Syndromic Multiplex Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Syndromic Multiplex Diagnostic Product
Table 50. Abbott Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Hologic Company Detail
Table 53. Hologic Business Overview
Table 54. Hologic Syndromic Multiplex Diagnostic Product
Table 55. Hologic Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 56. Hologic Recent Development
Table 57. Bosch Company Detail
Table 58. Bosch Business Overview
Table 59. Bosch Syndromic Multiplex Diagnostic Product
Table 60. Bosch Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 61. Bosch Recent Development
Table 62. Danaher Company Detail
Table 63. Danaher Business Overview
Table 64. Danaher Syndromic Multiplex Diagnostic Product
Table 65. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 66. Danaher Recent Development
Table 67. Johnson & Johnson Company Detail
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Syndromic Multiplex Diagnostic Product
Table 70. Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Danaher Company Detail
Table 73. Danaher Business Overview
Table 74. Danaher Syndromic Multiplex Diagnostic Product
Table 75. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 76. Danaher Recent Development
Table 77. Bio-Rad Laboratories Company Detail
Table 78. Bio-Rad Laboratories Business Overview
Table 79. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Product
Table 80. Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 81. Bio-Rad Laboratories Recent Development
Table 82. Luminex Company Detail
Table 83. Luminex Business Overview
Table 84. Luminex Syndromic Multiplex Diagnostic Product
Table 85. Luminex Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 86. Luminex Recent Development
Table 87. bioMérieux Company Detail
Table 88. bioMérieux Business Overview
Table 89. bioMérieux Syndromic Multiplex Diagnostic Product
Table 90. bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 91. bioMérieux Recent Development
Table 92. Qiagen Company Detail
Table 93. Qiagen Business Overview
Table 94. Qiagen Syndromic Multiplex Diagnostic Product
Table 95. Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Alveo Technologies Company Detail
Table 98. Alveo Technologies Business Overview
Table 99. Alveo Technologies Syndromic Multiplex Diagnostic Product
Table 100. Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 101. Alveo Technologies Recent Development
Table 102. Mesa Biotech Company Detail
Table 103. Mesa Biotech Business Overview
Table 104. Mesa Biotech Syndromic Multiplex Diagnostic Product
Table 105. Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 106. Mesa Biotech Recent Development
Table 107. Applied BioCode Company Detail
Table 108. Applied BioCode Business Overview
Table 109. Applied BioCode Syndromic Multiplex Diagnostic Product
Table 110. Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 111. Applied BioCode Recent Development
Table 112. Akonni Biosystems Company Detail
Table 113. Akonni Biosystems Business Overview
Table 114. Akonni Biosystems Syndromic Multiplex Diagnostic Product
Table 115. Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 116. Akonni Biosystems Recent Development
Table 117. Diagenode Diagnostics Company Detail
Table 118. Diagenode Diagnostics Business Overview
Table 119. Diagenode Diagnostics Syndromic Multiplex Diagnostic Product
Table 120. Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2018-2023) & (US$ Million)
Table 121. Diagenode Diagnostics Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Syndromic Multiplex Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Syndromic Multiplex Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Gastrointestinal Syndromic Multiplex Diagnostic Features
Figure 4. Central Nervous System Syndromic Multiplex Diagnostic Features
Figure 5. Others Features
Figure 6. Global Syndromic Multiplex Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Syndromic Multiplex Diagnostic Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Laboratories Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Syndromic Multiplex Diagnostic Report Years Considered
Figure 13. Global Syndromic Multiplex Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Syndromic Multiplex Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Syndromic Multiplex Diagnostic Market Share by Region: 2022 VS 2033
Figure 16. Global Syndromic Multiplex Diagnostic Market Share by Players in 2022
Figure 17. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syndromic Multiplex Diagnostic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Syndromic Multiplex Diagnostic Revenue in 2022
Figure 19. North America Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Syndromic Multiplex Diagnostic Market Share by Country (2018-2033)
Figure 21. United States Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Syndromic Multiplex Diagnostic Market Share by Country (2018-2033)
Figure 25. Germany Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Region (2018-2033)
Figure 33. China Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Syndromic Multiplex Diagnostic Market Share by Country (2018-2033)
Figure 41. Mexico Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Country (2018-2033)
Figure 45. Turkey Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Syndromic Multiplex Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 48. Hologic Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 49. Bosch Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 50. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 51. Johnson & Johnson Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 52. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 54. Luminex Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 55. bioMérieux Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 56. Qiagen Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 57. Alveo Technologies Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 58. Mesa Biotech Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 59. Applied BioCode Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 60. Akonni Biosystems Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 61. Diagenode Diagnostics Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed